Dianging Wu

Title: The Innovations of Dianging Wu

Introduction

Dianging Wu is an accomplished inventor based in Lake Placid, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has the potential to impact various medical applications, especially in cancer research and treatment.

Latest Patents

Dianging Wu holds a patent for "Hybridomas producing monoclonal antibodies which specifically bind to the human EGF receptor." This patent describes hybridomas that produce monoclonal antibodies capable of competing with EGF for binding to the EGF receptor. The antibodies bind to an epitope located between residues Ala-351 and Asp-364 of the EGF receptor, which remains stable under various conditions, including boiling and treatment with detergents or reducing agents. This innovation is crucial for advancing therapeutic strategies targeting the EGF receptor.

Career Highlights

Wu is associated with the W. Alton Jones Cell Science Center Incorporated, where he has been instrumental in research and development. His expertise in monoclonal antibody technology has positioned him as a key figure in his field. With a focus on innovative solutions, he continues to contribute to advancements in biotechnology.

Collaborations

Some of his notable coworkers include J Denry Sato and Lihua Wang. Their collaborative efforts have further enhanced the research output and innovation at the W. Alton Jones Cell Science Center.

Conclusion

Dianging Wu's contributions to the field of biotechnology, particularly through his patent on monoclonal antibodies, highlight his role as an influential inventor. His work not only advances scientific knowledge but also holds promise for future medical applications.